Abstract
A new series of pyrimidinesulfamoyl-1H-pyrrole-3-carboxamides (3a-e) and pyrimidinesulfamoyl-1Hpyrazole- 3-carboxamides (4a-e) moiety was prepared using intermediate compounds pyrimidinesulfamoyl cinnamamides (2a-e). On the basis of the FT-IR, 1H NMR, 13C NMR, LCMS spectral results and elemental analysis data, the structures of newly synthesized compounds were confirmed. Based on results of their in-vitro antioxidant activities, compounds such as 3b, 3c and 3d exhibited promising antioxidant activities and while remaining compounds such as 4c, 4b, 3a, 4d, 4a, 3e, 4e and 2c showed moderate to good antioxidant activity.
Keywords: Antioxidant activity, synthesis, pyrimidin-2-yl-sulfamoyl-cinnamamide, pyrrole-3-carboxamides, pyrazole-3- carboxamides.
Letters in Organic Chemistry
Title:New Class of Pyrimidinesulfamoyl Containing Pyrazole and Pyrrole Derivatives and Their Antioxidant Activity
Volume: 10 Issue: 5
Author(s): Suresh Maddila and Sreekanth B. Jonnalagadda
Affiliation:
Keywords: Antioxidant activity, synthesis, pyrimidin-2-yl-sulfamoyl-cinnamamide, pyrrole-3-carboxamides, pyrazole-3- carboxamides.
Abstract: A new series of pyrimidinesulfamoyl-1H-pyrrole-3-carboxamides (3a-e) and pyrimidinesulfamoyl-1Hpyrazole- 3-carboxamides (4a-e) moiety was prepared using intermediate compounds pyrimidinesulfamoyl cinnamamides (2a-e). On the basis of the FT-IR, 1H NMR, 13C NMR, LCMS spectral results and elemental analysis data, the structures of newly synthesized compounds were confirmed. Based on results of their in-vitro antioxidant activities, compounds such as 3b, 3c and 3d exhibited promising antioxidant activities and while remaining compounds such as 4c, 4b, 3a, 4d, 4a, 3e, 4e and 2c showed moderate to good antioxidant activity.
Export Options
About this article
Cite this article as:
Maddila Suresh and Jonnalagadda Sreekanth B., New Class of Pyrimidinesulfamoyl Containing Pyrazole and Pyrrole Derivatives and Their Antioxidant Activity, Letters in Organic Chemistry 2013; 10 (5) . https://dx.doi.org/10.2174/1570178611310050013
DOI https://dx.doi.org/10.2174/1570178611310050013 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Drug Therapy of Neuropathic Pain: Current Developments and Future Perspectives
Current Drug Targets The Critical Role of Vascular Endothelial Growth Factor in Tumor Angiogenesis
Current Cancer Drug Targets The Molecular Basis of the Interplay between Endothelin-1 and Nitric Oxide and its Relevance for Atherosclerosis and Arterial and Pulmonary Hypertension
Vascular Disease Prevention (Discontinued) Dissecting Insulin Signaling Pathways: Individualised Therapeutic Targets for Diagnosis and Treatment of Insulin Resistant States
Endocrine, Metabolic & Immune Disorders - Drug Targets Cardiovascular Complications in Patients with Klinefelter’s Syndrome
Current Pharmaceutical Design Novel Anti-Platelets in Stable Coronary Artery Disease
Current Pharmaceutical Design The Antioxidant Response as a Drug Target in Diabetic Neuropathy
Current Drug Targets Anti-Cancer, Pharmacokinetic and Biodistribution Studies of Cremophor EL Free Alternative Paclitaxel Formulation
Current Drug Safety Why are People with “Poor Lung Function” At Increased Atherothrombotic Risk?A Critical Review with Potential Therapeutic Indications
Current Vascular Pharmacology Metabolic Enzymes of Helminth Parasites: Potential as Drug Targets
Current Protein & Peptide Science Non Invasive Indexes for the Assessment of Patients with Non-alcoholic Fatty Liver Disease
Current Pharmaceutical Design C-Reactive Protein and Hypertension: Is there A Causal Relationship?
Current Pharmaceutical Design Correlation of Urine Biomarkers: Microalbuminuria and Spot Urine Protein among Diabetic Patients. Application of Spot Urine Protein in Diabetic Kidney Disease, Nephropathy, Proteinuria Estimation, Diagnosing and Monitoring
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Nutrigenomic Analysis of Diet-Gene Interactions on Functional Supplements for Weight Management
Current Genomics Relationship Between Inflammation, Insulin Resistance and Type 2 Diabetes: Cause or Effect?
Current Diabetes Reviews Inflammatory Markers in Coronary Artery Disease: Pathophysiological Mechanisms, Prognostic and Therapeutic Implications
Current Cardiology Reviews Conjugation of Resveratrol with RGD and KGD Derivatives
Protein & Peptide Letters Efficacy and Safety Outcomes of Short Duration Antiplatelet Therapy with Early Cessation of Aspirin Post Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis
Current Cardiology Reviews The potential for circulating microRNAs in the diagnosis of myocardial infarction: a novel approach to disease diagnosis and treatment
Current Pharmaceutical Design Familial Combined Hyperlipidaemia: Under - Defined and Under - Diagnosed?
Current Vascular Pharmacology